Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.

RPEP-140652025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.
Published In:
The Journal of clinical endocrinology and metabolism, 110(10), 2964-2979 (2025)
Database ID:
RPEP-14065

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-14065·https://rethinkpeptides.com/research/RPEP-14065

APA

Wang, Yahao; Zhou, Yue; Wang, Zhihong; Ni, Yunzhi; Prud'homme, Gerald J; Wang, Qinghua. (2025). Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.. The Journal of clinical endocrinology and metabolism, 110(10), 2964-2979. https://doi.org/10.1210/clinem/dgaf336

MLA

Wang, Yahao, et al. "Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.." The Journal of clinical endocrinology and metabolism, 2025. https://doi.org/10.1210/clinem/dgaf336

RethinkPeptides

RethinkPeptides Research Database. "Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-a..." RPEP-14065. Retrieved from https://rethinkpeptides.com/research/wang-2025-efficacy-of-glp1based-therapies

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.